There are many different types of Injectable Drugs. Almost every drug on the market can be injected. The process involves allowing the pills to dissolve in liquid and injecting the liquid into a vein. Injecting drugs into the body is an effective way to deliver these medications quickly to the brain. Unlike oral drugs, which must first pass through the digestive tract and intestines, injectable drugs reach the brain quickly and efficiently. This method produces a high that lasts only a few seconds before fading away to a standard high that lasts for 20 to 30 minutes
Key players operating in the market are focusing on receiving product approvals from regulatory authorities. This is projected to drive the market growth over the forecast period.
To Get More Business Strategies Sample Copy of Report @ https://www.coherentmarketinsights.com/insight/request-sample/4891
For instance, in August 2020, Novartis, a global healthcare company based in Switzerland, announced that the U.S. Food and Drug Administration (FDA) approved Kesimpta (precisely dosed and delivered B-cell therapy), injection for subcutaneous utilization for the treatment of multiple sclerosis, and active secondary progressive disease, in adults.
Middle East and Asia Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
COVID-19 outbreak was first reported on December 31, 2019, in Wuhan, China. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 260 million cases and 5.2 million deaths due to Coronavirus (COVID-19) were reported up till November 29, 2021, across the globe.
Drug shortage has been frequently noticed over the past few years in Saudi Arabia due to various reasons. Both locally and globally, this pandemic has exacerbated each and every situation. Saudi Arabia’s drug shortage is described and characterized by few of the studies before pandemic. The local manufacturers only covered 20-26% of domestic drug imports in which the different healthcare entities failed to inform the Saudi Food and Drug Authority (SFDA) regarding the drug shortages.
The main reason behind frequently noticed drug shortages is some old and essential drugs low profit margin and unadaptable traditional public procurement policy.
Inquire More Or Share Questions If Any Before The Purchase On This Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/4891
Key players operating in the market are focusing on adoption of inorganic growth strategies such as mergers, collaborations, partnerships, and acquisitions, in order to strengthen their position in the global market. For instance, in November 2021, BioMarin Pharmaceutical Inc., a world leader in developing and commercializing innovative biopharmaceuticals, announced that the U.S. FDA had approved VOXZOGO injection, which is used in increasing the linear growth in pediatric patients.
Key Takeaways of the Middle East and Asia Injectable Drugs Market
- Middle East and Asia injectable drugs market is expected to exhibit a CAGR of 8.2% over the forecast period, due to increasing launches, agreement and regulatory approvals of products. For instance, in July 2017, GlaxoSmithKline plc, a British multinational pharmaceutical company headquartered in London, England, announced that the U.S. FDA had approved new subcutaneous formulation of Benlysta for the therapy of adult patients who are obtaining standard treatment.
- Among product type, pre-filled syringes is expected to account for largest market share during the forecast period, due to product approvals by key players to meet demand for prefilled syringes with safety features and technological improvements. For instance, pre-filled syringes segment in Middle East and Asia injectable drugs market is estimated to be valued at US$ 415,000 Mn in 2021, and is projected to increase to US$ 7, 23,164 Mn by 2028, witnessing a CAGR of 8.2% during the forecast period.
- Major players operating in the Middle East and Asia injectable drugs market include Kalbe Farma, Takeda pharmaceuticals Co. Ltd., Livzon Pharmaceutical Group, Inc., Sun Pharmaceutical Industries, Ltd., Pfizer, Inc., Sanofi, Novartis, Tabuk, Novo Nordisk, GlaxoSmithKline plc, AstraZeneca, and Gerresheimer AG
Purchase This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/4891
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Drug Class
- Market Snippet, By Route of Administration
- Market Snippet, By End Users
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product approval and launches
- Merges and Acquisitions
- Key development
- Middle East and Asia drug approval process
- Regulatory Scenario
- Reimbursement Scenario
- Brand Analysis
- PEST Analysis
- Pricing Analysis
- Technology Advancement
- Market Dynamics
- Middle East and Asia Injectable Drugs Market – Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Clinical Trials and Drug Development
- Government Initiatives
- Middle East and Asia Injectable Drugs Market, By Product Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Pre-filled Syringes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Vaccines
- Blood Stimulants
- Biologics
- Others
- Auto-injectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pre-filled Pens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Pre-mixed IV Bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Sedative Products (Sedation)
- Anesthesia Products (Anesthesia)
- Pain Management Products (Post-operative analgesic pain management)
- Chemotherapy Products (Chemotherapy)
- Antibacterial Products (Infectious diseases)
- Electrolyte and Nutrition Products (Electrolyte and Nutrition)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Middle East and Asia Injectable Drugs Market, By Route of Administration, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Intravenous (IV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Intramuscular (IM)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Subcutaneous (SC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others (Epidural and Intrathecal)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Middle East and Asia Injectable Drugs Market, By Drug Class , 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antidotes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antiemetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Anti-infective
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Anti-thrombolytic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Muscle Relaxant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Non Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Sedatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Middle East and Asia Injectable Drugs Market, By End Users, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Email: sales@coherentmarketinsights.com
Phone: U.S.: +1-206-701-6702
U.K.: +44-020-8133-4027
JAPAN: +81-50-5539-1737
INDIA: +91-848-285-0837